NovaBay Pharmaceuticals (NBY) Current Leases (2019 - 2025)
Historic Current Leases for NovaBay Pharmaceuticals (NBY) over the last 7 years, with Q3 2025 value amounting to $416000.0.
- NovaBay Pharmaceuticals' Current Leases rose 666.67% to $416000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $416000.0, marking a year-over-year increase of 666.67%. This contributed to the annual value of $398000.0 for FY2024, which is 815.22% up from last year.
- As of Q3 2025, NovaBay Pharmaceuticals' Current Leases stood at $416000.0, which was up 666.67% from $409000.0 recorded in Q2 2025.
- Over the past 5 years, NovaBay Pharmaceuticals' Current Leases peaked at $485000.0 during Q3 2023, and registered a low of $195000.0 during Q3 2021.
- In the last 5 years, NovaBay Pharmaceuticals' Current Leases had a median value of $403000.0 in 2025 and averaged $394210.5.
- Per our database at Business Quant, NovaBay Pharmaceuticals' Current Leases tumbled by 5192.31% in 2021 and then soared by 12820.51% in 2022.
- NovaBay Pharmaceuticals' Current Leases (Quarter) stood at $200000.0 in 2021, then skyrocketed by 126.5% to $453000.0 in 2022, then fell by 18.76% to $368000.0 in 2023, then increased by 8.15% to $398000.0 in 2024, then increased by 4.52% to $416000.0 in 2025.
- Its last three reported values are $416000.0 in Q3 2025, $409000.0 for Q2 2025, and $403000.0 during Q1 2025.